98%
921
2 minutes
20
Decreasing responsiveness to repeated visual stimuli (i.e., the inability to sustain attention) in jumping spiders (Salticidae) parallels that found in humans. In humans, drugs affect vigilance, and previous work on salticids has shown that the "vigilance decrement" is unlikely to be sensory habituation and that caffeine ameliorates reductions in attention. We exposed to delta-9 tetrahydrocannabinol (THC) and methamphetamine before presenting them with a repeated visual stimulus. In the THC experiment, spiders were given a THC solution, water, or a vehicle solution, using a within-subjects design. The orienting response (i.e., "interest") of salticids on a track ball to face a fly stimulus presented peripherally on a monitor was scored, as well as "general movement" (e.g., walking, as a control for physical fatigue) and "no movement." The methamphetamine experiment was identical except that salticids were given methamphetamine solution or water. In both the THC and methamphetamine treatments, general movement dropped over time, while in control treatments, this was constant. Additionally, due to an initial stimulating effect of methamphetamine on interest, the response decrement was significantly steeper when spiders were administered methamphetamine compared with water. Our results suggest that the modulation of sustained attention, and possibly motivation, is likely in salticids. basic local alignment search tool genome queries on a closely related species and pharmacological radioligand experiments suggested that salticids do not possess cannabinoid receptors, but the presence of transient receptor potential proteins may help explain the small behavioral changes observed with THC. In contrast, how methamphetamine affects salticids remains unknown. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1037/com0000396 | DOI Listing |
Open Life Sci
September 2025
Physiology and Physiopathology Team, Faculty of Sciences, Genomic of Human Pathologies Research Centre, Mohammed V University in Rabat, Rabat, Morocco.
The legalization of cannabis for industrial and medicinal purposes has significantly expanded worldwide. This study delves into the analgesic potential toxicity study of chloroformic extract from the Moroccan L. () cultivar, Khardala (KH extract).
View Article and Find Full Text PDFHum Psychopharmacol
September 2025
Psychology and Neuroscience, University of Colorado Boulder, Boulder, Colorado, USA.
Objective: This study examined the effects of tetrahydrocannabinol (THC) and cannabidiol (CBD) on negative mood and drinking behaviors, and whether those effects were moderated by levels of perceived discrimination among participants who identify with a racial, ethnic, gender, or sexual identity that is underrepresented in research.
Methods: Participants were either not using cannabis, using cannabis with THC, or using cannabis with CBD and were assessed at baseline, 2 weeks, and 4-weeks following ad libitum use of a legal market cannabis product that was randomly assigned to them. Primary outcomes included scores on the Depression Anxiety Stress (DASS) Scale and number of drinking days.
Cannabis
July 2025
Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College.
Objective: Estimating delta-9 tetrahydrocannabinol (mgTHC) using hits involves converting hits to grams via a grams-per-hit ratio (GPHR). Previous studies assumed a single hit size (SHS), ignoring individual hit size variations. This study investigates a multiple qualitative hit size (MQHS) approach based on self-reported hit sizes (small, medium, large) to improve mgTHC estimates.
View Article and Find Full Text PDFSci Adv
September 2025
Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
Despite effective antiretroviral therapy (ART), people with HIV (PWH) experience persistent inflammation and metabolic dysfunction, increasing their risk for non-AIDS comorbidities. Accordingly, we evaluated the effects of long-term/low-dose Δ-tetrahydrocannabinol (THC) supplementation in simian immunodeficiency virus (SIV)-infected, ART-treated rhesus macaques (RMs). THC significantly increased plasma/jejunum serotonin and indole-3-propionate, enhancing gut-brain communication through up-regulation of serotonin receptors (HTR4/HTR7) and aryl hydrocarbon receptor (Ahr) signaling via a cannabinoid receptor (CBR)-2-mediated mechanism.
View Article and Find Full Text PDFFront Adolesc Med
March 2025
Department of Psychiatry, University of Illinois at Chicago.
Introduction: Cannabis and its main psychoactive constituent, delta-9-tetrahydrocannabinol (THC), are thought to weaken neurocognitive processes. However, past experimental research examining the acute effects of THC on neurocognition has produced mixed results. The current study aims to advance this literature through application of computational modeling and consideration of individual differences in cannabis use history and subjective drug effects.
View Article and Find Full Text PDF